Vivos Therapeutics Inc (VVOS NASDAQ) stock market data APIs
$0.5855
0.01(1.7%)
as of May 19, 2026
Try our APIs with
free plan!
Vivos Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Prev. Close
0.5855
Open
0.5915
High
0.6489
Low
0.5769
52 wk Range
0.58-7.95
Market Cap
8 024 K
Shares Outstanding
13 714 K
Revenue
17 443 K
EPS
0
Beta
6.209
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vivos Therapeutics Inc data using free add-ons & libraries
Get Vivos Therapeutics Inc Fundamental Data
Vivos Therapeutics Inc Fundamental data includes:
- Net Revenue: 17 443 K
- EBITDA: -18 585 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-18
- EPS/Forecast: -0.415
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vivos Therapeutics Inc News
New
Vivos Therapeutics Inc Full Year Sales Increase
(RTTNews) - Vivos Therapeutics Inc (VVOS) released Loss for full year of -$21.17 million The company's earnings came in at -$21.17 million, or -$2.07 per share. This compares with -$11.14 million, o...
Vivos targets cash flow positive operations by end of 2026 as it scales SO teams with $500,000+ monthly collections potential
Earnings Call Insights: Vivos Therapeutics (VVOS) Q4 2025 MANAGEMENT VIEW * “2025 was a pivotal year for Vivos,” said (Co-Founder, Chairman of the Board & CEO R. Kirk Huntsman), adding that th...
Vivos Therapeutics Reports Full Year 2025 Financial Results
Full Year 2025 revenue increased 16% Integration of The Sleep Center of Nevada and shift in business model support path to improved revenues, margins and cash flow Management to Host Conference Call...
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)
Special continuing M&A Segment with Senior M&A Partner at Sullivan & Cromwell LLP, Frank Aquila NEW YORK CITY, NY / ACCESS Newswire / April 11, 2026 / New to The Street announces its latest nationall...
Get Vivos Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
